Track the Ambu A/S stock price and the full directors' dealings record of the company, a publicly traded company based in Denmark. Shares trade on the DK market, under the oversight of Finanstilsynet DK. Operating in the Health Care sector, Ambu A/S has recorded 228 reports. Market capitalisation: €18.7bn. The latest transaction was reported on 9 June 2026 (Purchase). Among the most active insiders: Britt Meelby Jensen. The full history is openly available.
228
Insider Decl.
n/a
Thresholds
€6m
13 ops.
Buy Volume
€385m
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Ambu A/S Buy (bullish), based on 8 analysts. Average price target: DKK 87.30.
38Σ signal
Buys €6m€385m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 13,912 of 28,932 companies
53.0
score / 100
Value
42
Quality
64
FCF yld3.0%
Earn yld1.4%
EV/EBITDA17.4x
ROE7.9%
Gross mgn59%
Net mgn4.4%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
328 shares@ DKK 235.810.0000% mcap0.0% of flowShareOutside a trading venue (shares received after vesting will be listed onISINISIN DK0060946788DK:1034032
625 shares@ DKK 235.810.0001% mcap0.0% of flowShareOutside a trading venue (shares received after vesting will be listed onISINISIN DK0060946788DK:1034030
39,000 shares@ DKK 190.080.0029% mcap0.3% of flowShareNasdaq CopenhagenISINISIN DK0060946788DK:976293
25 of 228 declarations
About Ambu A/S
Ambu A/S is a Danish company that specializes in the development and manufacturing of medical devices. It primarily focuses on products for resuscitation, anesthesia, and patient monitoring.